Shahrokh Shabahang
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Shahrokh Shabahang is the founder of Sekris Biomedical, Inc., founded in 2009, serving as Chairman & Chief Executive Officer since 2009.
Dr. Shabahang is the founder of Aditxt, Inc., founded in 2017, serving as Chief Innovation Officer since 2026.
Former jobs include Director-Microbiology at Loma Linda University and Secretary at Genelux Corp.
from 2004 to 2007.
Education history includes a doctorate from Loma Linda University conferred in 2001 and a doctorate from the University of the Pacific conferred in 1987.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADITXT, INC. -.--% | 01/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ADITXT, INC. | Fondateur | 28/09/2017 |
Sekris Biomedical, Inc. | Directeur Général | 01/01/2009 |
| Sociétés | Poste | Fin |
|---|---|---|
| GENELUX CORPORATION | Secrétaire Général | 01/01/2007 |
Loma Linda University
Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
Sekris Biomedical, Inc. | |
Loma Linda University
Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aditxt, Inc.
Aditxt, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops immunosuppressive anti-rejection and monoclonal drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national